首页>投融资
Bio Med Sciences
收并购
自 1987 年以来,Bio Med Sciences 一直致力于为世界各地的医疗保健提供商和消费者提供创造性的解决方案,从而改善人们的生活。我们的 Silon® 技术融合了有机硅和 Teflon® 的最佳特性,使我们能够开发出用于伤口护理、疤痕管理和皮肤更新技术的创新产品。
基本信息
-
公司全称Bio Med Sciences Inc
-
类型伤口护理、疤痕管理产品开发商
-
产业领域医疗器械、治疗设备
-
公司人数15~50人
-
地址999 Postal Road Allentown
-
联系电话1-800-257-4566
-
邮箱biomedcs@silon.com
-
成立时间1987-01-01
投融资
-
2024-05-31收并购未透露Wacker
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。